Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00116623 · ClinicalTrials.gov registry record · Phase 4
Magnesium Sulfate Versus Indomethacin for Preterm Labor
A Phase 4 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00116623: Clinical Trial Phase 4 study, sponsored by University of Pennsylvania.
NCT00116623 is a Phase 4 study that was terminated before completion, run by University of Pennsylvania. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00116623, a Phase 4 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to investigate the efficacy of Indomethacin compared to Magnesium Sulfate (MgSO4) in reducing neonatal morbidity through a prospective double blind randomized clinical trial. The specific aim of the project is to test the hypothesis that Indomethacin, compared to MgSO4, will decrease the proportion of neonates diagnosed with major complications or death.
Interventions
- DRUG Indomethacin
- DRUG Magnesium sulfate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-02 |
| Est. Completion | 2006-02 |
| Phase | Phase 4 |
Why NCT00116623 stopped before completion
NCT00116623 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Indomethacin is the first listed.
NCT00116623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00116623 about?
NCT00116623 is a clinical study titled "Magnesium Sulfate Versus Indomethacin for Preterm Labor". The purpose of this study is to investigate the efficacy of Indomethacin compared to Magnesium Sulfate (MgSO4) in reducing neonatal morbidity through a prospective double blind randomized clinical trial. The specific aim of the project is to test the hypothesis that Indomethacin, compared to MgSO4, ...
What is the current status of trial NCT00116623?
This trial is currently terminated. It is a Phase 4 study. The study started on 2003-02. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00116623?
The interventions under investigation include: Indomethacin (DRUG), Magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT00116623?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia